The 2020 ACR Review Course: Key Issues Rheumatologists Face
Osteoporosis Experts Discuss Bisphosphonate Holidays
New Findings on Hydroxychloroquine, Denosumab
Bisphosphonates Reduce Bone Toughness Over Time
Abaloparatide vs. Alendronate for Osteoporosis
Denosumab Dosing Delays Tied to Increased Fracture Risk
Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD
Zoledronate After Denosumab Does Not Fully Prevent Bone Loss
After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk
- 1
- 2
- 3
- …
- 18
- Next Page »